Collin Van Ryn
University of Minnesota(US)University of Minnesota System(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Viral Infections and Outbreaks Research, Neuroendocrine Tumor Research Advances, Adrenal and Paraganglionic Tumors
Most-Cited Works
- → Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial(2017)270 cited
- → Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma(2017)169 cited
- → Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials(2017)165 cited
- → Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group(2017)144 cited
- → MYCN amplification and ATRX mutations are incompatible in neuroblastoma(2020)124 cited
- → Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study(2016)56 cited
- → MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group(2017)51 cited
- → MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group(2017)39 cited
- → Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma(2018)33 cited
- → Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study(2019)32 cited